Publicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (55)

2023

  1. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile

    Biomedicine and Pharmacotherapy, Vol. 162

2022

  1. Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress

    Cardiovascular research, Vol. 118, Núm. 16, pp. 3250-3268

  2. Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity

    British Journal of Pharmacology, Vol. 179, Núm. 11, pp. 2733-2753

2021

  1. Epigenetics in precision medicine of cardiovascular disease

    Epigenetics in Precision Medicine (Elsevier), pp. 347-368

  2. Monocyte low-density lipoprotein receptor-related protein 1 (Lrp1) expression correlates with CIMT in Mexican hypertensive patients

    Arquivos Brasileiros de Cardiologia, Vol. 116, Núm. 1, pp. 56-65

  3. Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 23, Núm. 5, pp. 682-690

2020

  1. Altered brain metabolome is associated with memory impairment in the rTG4510 mouse model of tauopathy

    Metabolites, Vol. 10, Núm. 2

  2. Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical-Cellular) Screening System

    Advanced Therapeutics, Vol. 3, Núm. 8

  3. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology

    Translational Research, Vol. 215, pp. 86-101

  4. Evaluation of biochemical and hematological parameters in adults with Down syndrome

    Scientific Reports, Vol. 10, Núm. 1

  5. Immunization with the Gly1127-Cys1140 amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies

    Theranostics, Vol. 10, Núm. 7, pp. 3263-3280

  6. LRP1-Mediated AggLDL Endocytosis Promotes Cholesteryl Ester Accumulation and Impairs Insulin Response in HL-1 Cells

    Cells, Vol. 9, Núm. 1

  7. Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity

    Metabolism: Clinical and Experimental, Vol. 106

  8. Macrophage cholesterol efflux downregulation is not associated with abdominal aortic aneurysm (AAA) progression

    Biomolecules, Vol. 10, Núm. 4

  9. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

  10. Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker

    FASEB Journal, Vol. 34, Núm. 3, pp. 4403-4414

  11. Subcutaneous administration of apolipoprotein j-derived mimetic peptide d-[113–122]apoj improves LDL and HDL function and prevents atherosclerosis in LDLR-KO mice

    Biomolecules, Vol. 10, Núm. 6

2019

  1. Circulating miRNAs as mediators in cell-to-cell communication

    Epigenomics

  2. Circulating microRNAs in suspected stable coronary artery disease: A coronary computed tomography angiography study

    Journal of Internal Medicine, Vol. 286, Núm. 3, pp. 341-355

  3. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: A novel tool for personalized medicine?

    European Heart Journal, Vol. 40, Núm. 20, pp. 1643-1650